Gritstone and Genevant Sciences Announce License Agreement for COVID-19 Vaccine

    NEXT STORY
    Swine Healthcare Market – Growth, Trends, and Forecasts (2021 – 2026)
    PREV STORY
    Pfizer and BioNTech Publish Results of Study Showing COVID-19 Vaccine Elicits Antibodies that Neutralize Pseudovirus Bearing the SARS-CoV-2 U.K. Strain Spike Protein in Cell Culture
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Merus kündigt Präsentation der klinischen Daten der Phase I für MCLA-158 auf dem „2021 Gastrointestinal Cancers Symposium“ der American Society of Clinical Oncology (ASCO) an

    author_avatar
    NASDAQ Market News

    pSivida’s Second Phase 3 Study for Durasert™ Three-year Treatment for Posterior Segment Uveitis Maintains Positive Efficacy and Safety Profile at 12 Months

    Highly Significant Difference Between Durasert and Sham in Prevention of Uveitis Recurrence at 12 Months ...

    author_avatar
    NASDAQ Market News

    Mersana Appoints David A. Spellman as Chief Financial Officer

    CAMBRIDGE, Mass., March 12, 2018 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage ...

    author_avatar
    NASDAQ Market News